Possibly, the main apparently conflictual evidence arising is that Th17 are not different between PD patients and controls when assessed by means of Th17-associated surface markers, while they are increased if assayed as IL-17+ cells (Tables 2, 3). Here, IL17A is linked to Parkinson disease.